WiStride Launches B2B App to Ease Challenges of
Pharma Biz
Co-Founder, WiStride Salim Shaikh Dr. Madhu Talla Ashwinder Singh Chowdhary.
WiStride, the first-ever Intelligence-Powered, Integrated B2B
Platform for active pharmaceuticalingredients (APIs), Intermediates and Raw
Materials, launched its new digital platform at an event held at the Emerald
Hall, Kohinoor Continental Hotel, Mumbai, on Friday (October 6 2023).
The Guest of Honour at the event was Mr
Satish Khanna, Chairman, Fullife Healthcare, Ex-Group President, Lupin and
Strategic Adviser, Author and Mentor. The Chief Guest for the event was Mr
Rakesh Bamzai, President, India, Emerging Asia and Access Markets, Viatris, and
CEO-MD, Mylan Laboratories Limited.
Ashwinder Singh Chowdhary and Salim
Shaikh, Co-founders, WiStride, officially launched the WiStride Digital
Platform in the presence of senior professionals of the pharma industry.
At the launch programme, Dr Madhu Talla,
Co-Founder, WiStride, said, “As we launch WiStride, we’re not just introducing
a platform, but we’re also ushering in a new era for the Pharma industry.
WiStride is set to revolutionize the way pharma buyers and sellers navigate
this landscape, creating a seamless journey that empowers both sides. It’s not
just about transactions; it’s also about AI-enabled intelligence-powered
transformation.”
WiStride’s services include Wistride
Edge and WiStride Commerce. WiStride Edge leverages the power of data
intelligence to provide vital market intelligence that directly addresses the
business challenges faced by clients. These insights are rooted in
comprehensive global research, real-time market dynamics, and extensive domain
expertise and state-of-the-art data science. This helps clients make agile and
well-informed decisions. WiStride Commerce, dedicated towards transforming the
pharmaceutical Business-to-Business (B2B) commerce landscape, aims to create a
trusted and transparent ecosystem.
WiStride Commerce is ready to connect
buyers and suppliers through its new digital platform, leading to cost saving
advantages and improved operational efficiency. The company will also offer
Supply Chain Financing options to help fund working capital requirements for
clients once they have identified the right partners using their platform.
About WiStride
WiStride, established in November 2022, was founded with the intent of
revolutionizing the active pharmaceutical ingredient (API) landscape within the
pharmaceutical industry. The company specializes in delivering tailored data
inputs and actionable insights to its clients, enabling them to make informed
decisions rooted in ‘Wisdom’ and take confident steps, or ‘Strides’, toward achieving
product excellence.
www.wistride.com